26
Simulation study stability Oxytocics Michiel de Goeje

Simulation study stability Oxytocics Michiel de Goeje

  • Upload
    alma

  • View
    27

  • Download
    0

Embed Size (px)

DESCRIPTION

Simulation study stability Oxytocics Michiel de Goeje. Study design. Simulation study of several products of several brands at several storage conditions Ergometrine injection Methylergometrine injection Oxytocine injection. Study design. Different brands 3 or 4 brands for each product - PowerPoint PPT Presentation

Citation preview

Page 1: Simulation study stability Oxytocics Michiel de Goeje

Simulation study stability OxytocicsMichiel de Goeje

Page 2: Simulation study stability Oxytocics Michiel de Goeje

- 2 -

Study design

Simulation study of several products of several brands at several storage conditions

Ergometrine injection

Methylergometrine injection

Oxytocine injection

Page 3: Simulation study stability Oxytocics Michiel de Goeje

- 3 -

Study design

Different brands•3 or 4 brands for each product

•2 batches of each brand

Different temperatures•2-8°C, RT(21°), 25°, 30°, 40°, 50°C

Different times•0; 0.5; 1; 2; 3; 6; 12; 24 months

Page 4: Simulation study stability Oxytocics Michiel de Goeje

- 4 -

Design

Influence of light

Manufacturing characteristics•pH, oxygen, antioxidants

Colour changes

Page 5: Simulation study stability Oxytocics Michiel de Goeje

- 5 -

Results and conclusion

Both Ergometrine as well as Methylergometrine are very sensitive to light.

Page 6: Simulation study stability Oxytocics Michiel de Goeje

- 6 -

Influence of light

Ergometrine

0

20

40

60

80

100

120

0 0.5 1 2 3 6 12 24

time (months)

acti

ve in

gre

die

nt

%

Lrm

Drm

Page 7: Simulation study stability Oxytocics Michiel de Goeje

- 7 -

Influence of light

Methylergometrine

0

20

40

60

80

100

120

0 0.5 1 2 3 6 12 24

time (months)

act

ive

ing

red

ien

t %

Lrm

Drm

Page 8: Simulation study stability Oxytocics Michiel de Goeje

- 8 -

Influence of light oxytocin

84

86

88

90

92

94

96

98

100

102

0 0.5 2 6 12 24

time (months)

act

ive in

gre

die

nt

(%)

D21

Lrm

Page 9: Simulation study stability Oxytocics Michiel de Goeje

- 9 -

Influence Temperature

Ergometrine

0

20

40

60

80

100

120

0 0.5 1 2 3 6 12 24

time (months)

acti

ve in

gre

die

nt

%D4-8

D21

Lrm

Drm

D25

D30

D40

D50

Page 10: Simulation study stability Oxytocics Michiel de Goeje

- 10 -

Influence Temperature

Methylergometrine

0

20

40

60

80

100

120

0 0,5 1 2 3 6 12 24

time (months)

acti

ve i

ng

red

ien

t %

D4-8

D21

Lrm

Drm

D25

D30

D40

D50

Page 11: Simulation study stability Oxytocics Michiel de Goeje

- 11 -

Influence Temperature oxytocin

0

20

40

60

80

100

120

0 0,5 2 6 12 24

time (months)

acti

ve i

ng

red

ien

t (%

) D4-8

D21

Lrm

D30

D40

D50

Page 12: Simulation study stability Oxytocics Michiel de Goeje

- 12 -

Difference in products

Average decrease in content after 1 year

Oxytocin is the most stable product

D4-8 D21 Lrm D25 D30

Ergometrine 5,1% 21% 91% 27% 31%

Methyl-ergometrine 3,7% 14% 91% 15% 18%

Oxytocin 0,0% 4,1% 7%   14%

Page 13: Simulation study stability Oxytocics Michiel de Goeje

- 13 -

Variability in stability of the different products

Relative Standard deviation in content after one year

  D4-8 D21 Lrm D30

Ergometrine 6% 27% 87% 24%

Methylergmetrine 5% 15% NA 18%

Oxytocin 1.1% 1.5% 2.5% 3.8%

Page 14: Simulation study stability Oxytocics Michiel de Goeje

- 14 -

Colour changes

Both Ergometrine and Methylergometrine show discolouration if degradation is more then 10%.

Slight colour changes are not easy detectable in the field

Coloured injection should not be used !

Page 15: Simulation study stability Oxytocics Michiel de Goeje

- 15 -

•The stability of ergometrine and methylergometrine is sensitive to changes in manufacturing proces

•Filling under nitrogen needed

•Oxytocin is more predictable in behaviour

Design and manufacturing conditions

Page 16: Simulation study stability Oxytocics Michiel de Goeje

- 16 -

Stability current suppliers IDA

Simulation study D4-8 D21 Lrm D25 D30

Ergometrine 5% 21% 91% 27% 31%

Methylergometrine 4% 14% 91% 15% 18%

Oxytocin 1.4% 5% 7%   15%

Average decrease in content after 1 year (%)

Current suppliers D4-8 D21 D25

Ergometrine 2 %   19 %

Methylergometrine   5 %* 2,4 %

Oxytocin 2 % 4 % 4 %

* Stability from a different brand

Page 17: Simulation study stability Oxytocics Michiel de Goeje

- 17 -

Stability current suppliers IDA

Oxytocin Labeled storage temperature 2-8°C (cool).The shelflife at this temperature is 3 years.

Advice for shelflife IDA products at higher temperature

• at 25°C the shelflife is reduced to 1 years.• at 30°C the shelflife is reduced to 6 months.• at 40°C transport maximum 1 week.

Page 18: Simulation study stability Oxytocics Michiel de Goeje

- 18 -

Stability current suppliers IDA

Methylergometrine Labeled storage temperature 2-8°C or 25° depending on manufacturerThe shelflife at this temperature is 2 years.

Advice for shelflife IDA products at higher temperature (only for manufacturer Gland)

• at 25°C the shelflife is 2 years• at 30°C the shelflife is reduced to 1 year• at 40°C transport maximum 4 weeks

Page 19: Simulation study stability Oxytocics Michiel de Goeje

- 19 -

Stability current suppliers IDA

ergometrine Labeled storage temperature 2-8°C The shelflife at this temperature is 2 years.

Advice for shelflife IDA products at higher temperature

• at 25°C the shelflife is reduced to 6 months• at 40°C transport maximum 2 weeks

Page 20: Simulation study stability Oxytocics Michiel de Goeje

- 20 -

Pharmacopoeial requirements on sensitivity to light

  BP2005 USP26

Ergometrineprotect from light

in a light resistant container

Methyl-ergmetrine

Not included

in a light resistant container

OxytocinNo require-ments

No require- ments

Page 21: Simulation study stability Oxytocics Michiel de Goeje

- 21 -

On storage temperature

Pharmacopoeial requirements

  BP2005 USP26

Ergometrine 2° to 8 °C 8-15 ºC

Methyl-ergometrine Not included No requirements

Oxytocin No requirements 2° to 8 °C

Page 22: Simulation study stability Oxytocics Michiel de Goeje

- 22 -

Quality assurance

Product should be procured through a reliable source.

BP assay is not specific for degradation products and therefore release and stability studies should be based on analysis by validated HPLC methods

Page 23: Simulation study stability Oxytocics Michiel de Goeje

- 23 -

Protect from light

Store refridgerated.

Manufacturer should be able to guarantee 2 years shelflife at refridgerated conditions.

Storage outside refridgeration (up to 30°C) may limit the shelflife to less then half year but is dependent on manufacturer.

Do not use coloured products.

Recommendation on storage ergometrine

Page 24: Simulation study stability Oxytocics Michiel de Goeje

- 24 -

Protect from light

Store refridgerated, although some brand may guarantee it up to 25°C

Manufacturer should be able to guarantee 2-3 years shelflife at refridgerated conditions.

Storage outside refridgeration may limit the shelflife to a year but is dependent on manufacturer.

Do not use coloured products.

Recommendation on storage methyl ergometrine

Page 25: Simulation study stability Oxytocics Michiel de Goeje

- 25 -

Recommended to store refridgerated.

It is expected to remain of sufficient quality if stored below 21°C up to 2 years.

When stored up to 30°C a loss of 15% in one year is expected. Thus shelflife is then limited to 6 months only.

Recommendation on storage Oxytocin

Page 26: Simulation study stability Oxytocics Michiel de Goeje

- 26 -

Simulation study stability Oxytocics

Stability data simulation study are based on study performed in collaboration with WHO WHO/DAP/93.6

Michiel de GoejePharmacist IDA Foundation